Gregorio, Reynante D.
HRN: 27-03-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
LEVOFLOXACIN 500MG (TAB)
05/03/2025
05/09/2025
PO
500mgtab
Q24
CAP LR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes